NDC 11673-295 - Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-295
- Package NDCs from labels
- 11673-295-03
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2024-08-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Target Daytime Cold & Flu and Nighttime Severe Cold & Flu Liquid | TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2024-08-22 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-295-03 | Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu | 180 mL in 1 BOTTLE | SOLUTION | 180 mL | 650 mg in 20mL | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-295 | MAXIMUM STRENGTH DAYTIME COLD AND FLU AND NIGHTTIME SEVERE COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE,TRIPROLIDINE HYDROCHLORIDE) KIT [TARGET CORPORATION] | 3 | Unmatched | 20240823_0fc523ce-55a7-6384-e063-6394a90aad3f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| GUAIFENESIN | GUAIFENESIN | CVS | 4efa8bf9-3394-47b4-b630-9476b15d2dfc | 2022-11-23 | Warnings | 495W7451VQ |
| Mucus Relief Extended Release | GUAIFENESIN | Care One (American Sales Company) | 96569c70-0936-4041-ab32-2b2262402f34 | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief Maximum Strength | GUAIFENESIN | Care One (American Sales Company) | c94e3943-20da-4bd4-b0ff-6aa60b03a1bf | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief | GUAIFENESIN | McKesson Corporation dba SKY Packaging | 69b61f05-8f0b-420f-b4ef-df933b70eebc | 2022-11-21 | Warnings | 495W7451VQ |
| GUNA-ARTHRO | .ALPHA.-KETOGLUTARIC ACID - ALPHA LIPOIC ACID - ASCORBIC ACID - BARIUM OXALOSUCCINATE - BLACK COHOSH - BRYONIA ALBA ROOT - CALCITONIN HUMAN - CHLORINE - COLCHICUM AUTUMNALE BULB - NADIDE - | Guna spa | 45ad3f03-0ee8-438f-81e7-3ca772022c98 | 2022-11-15 | Warnings | PQ6CK8PD0R |
| DG health mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Dolgencorp, LLC | add72ca5-94cd-437f-b30f-6149c08b5f21 | 2022-11-14 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Integra F | FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID | U.S. Pharmaceutical Corporation | 025fee85-53a8-4161-a806-44fd95d0ca74 | 2022-11-08 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Concept DHA | VITAMIN- MINERAL OMEGA-3 SUPPLEMENT | U.S. Pharmaceutical Corporation | bd2051f7-b887-46f6-8d4a-b099fcd08629 | 2022-11-08 | Warnings | PQ6CK8PD0R |
| Concept OB | VITAMIN MINERAL SUPPLEMENT | U.S. Pharmaceutical Corporation | 37992a25-68bd-4050-b936-596ddedc25a3 | 2022-11-08 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Mucus Relief | GUAIFENESIN | H E B | 562b6ab6-4795-4909-8008-e919173844c9 | 2022-11-07 | Warnings | 495W7451VQ |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | 14b238ab-904b-45dc-9eb9-a1074364e089 | 2022-11-07 | B22547B95K | |
| DAYTIME-NIGHTTIME SEVERE COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | KROGER | a2508699-08c0-4a22-e053-2a95a90a8a6d | 2022-11-02 | Warnings | M012 |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL B22547B95K | |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | 78933d4a-d78a-43bc-9052-a032901ee050 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL B22547B95K | |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | 5df7c033-0f31-45bc-8c34-3da45635e66d | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL B22547B95K | |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.